BLCO vs COO: Bausch + Lomb and Cooper Companies compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- Cooper Companies is the larger company, worth $10.6B, about 1.7 times Bausch + Lomb.
- Bausch + Lomb grew revenue faster over the last year (+9.1% vs +0.6%).
- Cooper Companies keeps more of each dollar of revenue as operating profit (12.8% vs 6.1%).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | BLCO | COO |
|---|---|---|
| Market cap | $6.1B | $10.6B |
| Share price | $17.30 | $54.37 |
| Revenue (last fiscal year) | $5.1B | $4.1B |
| Free cash flow (last fiscal year) | -$66M | $434M |
| Revenue growth, last year | +9.1% | +0.6% |
| Revenue growth per year, last 5 fiscal years | +7.9% | +8.8% |
| Operating margin | 6.1% | 12.8% |
| Net margin | -3.2% | 13.5% |
| Return on equity | -2.7% | 6.8% |
| P/E (trailing) | — | 27.1x |
| Price / free cash flow | — | 24.5x |
| EV / EBITDA | 14.9x | 14.0x |
| FCF growth the price implies | — | 7.7% |
| Dividend yield | — | — |
| Debt / equity | 1.16x | 0.52x |
| Fundamental grade | D | C |
| Superinvestors holding it | 0 | 11 |
| Insider purchases, last 12 months | 3 | 10 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
Bausch + Lomb
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $3.8B | $680M | 8.7% |
| 2022 | $3.8B | $170M | 5.5% |
| 2023 | $4.1B | -$198M | 3.1% |
| 2024 | $4.8B | -$59M | 3.4% |
| 2025 | $5.1B | -$66M | 2.2% |
Cooper Companies
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $2.9B | $524M | 17.3% |
| 2022 | $3.3B | $450M | 15.3% |
| 2023 | $3.6B | $215M | 14.8% |
| 2024 | $3.9B | $288M | 18.1% |
| 2025 | $4.1B | $434M | 16.7% |
Where the revenue comes from
Bausch + Lomb · by segments, 2025
Vision Care$2.9B57%
Pharmaceuticals$1.3B25%
Surgical$894M18%
Cooper Companies · by segments, 2025
CooperVision$2.7B67%
CooperSurgical$1.3B33%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open BLCO in InvestinglyQuestions
Which is bigger, Bausch + Lomb or Cooper Companies?
Cooper Companies (COO), at $10.6B against $6.1B.
Which grows faster, BLCO or COO?
Bausch + Lomb: revenue grew +9.1% over the last year, against +0.6%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.